Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | -4.32% | -23.12% | -60.06% |
07-02 | Coherus BioSciences Grants Apotex License to Distribute Toripalimab in Canada | MT |
07-01 | Baird Trims Price Target on Coherus BioSciences to $8 From $9, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.06% | 153M | |
+16.63% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.56% | 14B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus BioSciences, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 08